MGC Pharmaceuticals Ltd (ASX:MXC) has traded 88 million shares in the first 45 minutes of trade, with the stock jumping 71% to $0.065.
Driving the investor momentum is details emerging that the company has signed a binding terms and conditions agreement with Varm Cosmo Inc. for its MGC Derma division to supply five of its cannabidiol cosmetic products in bulk form, to be sold to consumers as part of Varm Cosmo’s cosmetics range.
With a minimum agreed purchase quantity of 15,000 kilograms per month, the expected deal will generate circa $40 million in annual revenue for MGC Derma.
The MGC Derma division is a 51:49 joint venture with Dr. M. Burstein Ltd, of which MGC Pharmaceuticals owns 51% and holds management control.
Company Name · Code · Last · Change · Volume
MGC Pharmaceuticals Ltd · MXC · $0.065 · 71.05% · 88,084,263
Australian Mines Ltd · AUZ · $0.053 · -13.12% · 65,137,946
Magnum Gas & Power Ltd · MPE · $0.002 · 100% · 40,931,125
Range Resources Ltd · RRS · $0.002 · -33.33% · 38,614,460
Reffind Ltd · RFN · $0.016 · 14.29% · 33,234,044
Atlas Iron Ltd · AGO · $0.018 · 5.88% · 28,158,015
AVZ Minerals Ltd · AVZ · $0.180 · 12.50% · 24,951,416
Lakes Oil NL · LKO · $0.002 · 0% · 23,430,499
Laneway Resources Ltd · LNY · $0.003 · 0% · 19,706,583
Thred Ltd · THD · $0.014 · 16.67 · 19,401,095